Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2023-04-28 Annual Report
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
2022 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is a comprehensive report from Pharmaron Beijing Co., Ltd. covering the full fiscal year ended December 31, 2022. It includes detailed sections such as Chairman's Statement, Financial Highlights, Management Discussion and Analysis, Corporate Governance Report, Directors' Report, Independent Auditor's Report, and full consolidated financial statements including profit or loss, comprehensive income, financial position, changes in equity, cash flows, and notes. The presence of these detailed financial statements and extensive management commentary indicates this is a full annual report. The document length is substantial (15,000 characters), and it is not merely an announcement or a brief summary. Therefore, it fits the definition of an Annual Report (10-K). FY 2022
2023-04-28 English
2023 FIRST QUARTERLY REPORT
Interim / Quarterly Report Classification · 100% confidence The document is titled '2023 FIRST QUARTERLY REPORT' and contains detailed financial data for the first quarter of 2023, including revenue, net profit, earnings per share, and segment performance. It references compliance with Hong Kong Stock Exchange listing rules and includes comprehensive financial indicators and analysis. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. It explicitly states it is a quarterly report and includes unaudited financial data for the quarter. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2023
2023-04-27 English
(1) PROPOSED REPURCHASE AND CANCELLATION OF PART OF THE RESTRICTED A SHARES GRANTED UNDER THE 2019 A SHARE INCENTIVE SCHEME&#x3b; (2) PROPOSED REDUCTION OF THE REGISTERED CAPITAL&#x3b; AND (3) PROPOSE
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Pharmaron Beijing Co., Ltd. regarding proposed corporate actions: repurchase and cancellation of restricted shares, reduction of registered capital, and amendments to the Articles of Association. It discusses board resolutions and proposals to be approved at the upcoming Annual General Meeting (AGM). The document is not a full report but an announcement of proposed corporate actions and upcoming shareholder meeting resolutions. It does not contain financial statements or detailed financial data. The content fits the category of a capital structure change announcement, specifically about share repurchase and capital reduction. According to the filing definitions, announcements about share repurchase or capital changes fall under 'Share Issue/Capital Change' (SHA). The document length (8241 characters) and detailed content support it being a substantive announcement rather than a brief notice or regulatory filing. Therefore, the appropriate classification is SHA with high confidence.
2023-04-27 English
(1) PROPOSED APPOINTMENT OF DIRECTORS OF THE THIRD SESSION OF THE BOARD&#x3b; (2) PROPOSED APPOINTMENT OF SUPERVISORS OF THE THIRD SESSION OF THE SUPERVISORY COMMITTEE&#x3b; AND (3) PROPOSED AMENDMENT
Board/Management Information Classification · 100% confidence The document is an announcement from Pharmaron Beijing Co., Ltd. regarding the proposed appointment of directors and supervisors for the third session of the board and supervisory committee, as well as proposed amendments to the articles of association due to changes in board composition. It includes detailed information about the nominations, qualifications, remuneration, and voting procedures related to these appointments. The document references compliance with listing rules and company law, and it is clearly an announcement of changes in the company's board and supervisory committee composition. There is no financial data or report content, but rather a governance-related announcement. Therefore, this fits the category of Board/Management Information (MANG).
2023-04-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-04-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings Classification · 95% confidence The document is extremely short (242 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another document. Per the 'Menu vs Meal' rule, this is a Report Publication Announcement.
2023-04-27 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.